Molnupiravir (Lagevrio)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Molnupiravir (Lagevrio), covering 2025-07-11 to 2025-07-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Molnupiravir Tablet Formulation Compared to the Molnupiravir Capsule Formulation in Healthy Adult Participants (MK-4482-011) [Phase 1]